BIOSTATISTICAL METHODOLOGY IN CLINICAL-TRIALS - A EUROPEAN GUIDELINE

被引：24

作者：

LEWIS, JA

JONES, DR

ROHMEL, J

机构：

[1] UNIV LEICESTER,DEPT EPIDEMIOL & PUBL HLTH,LEICESTER LE1 6TP,LEICS,ENGLAND

[2] FED INST DRUGS & MED PROD,D-13353 BERLIN,GERMANY

来源：

STATISTICS IN MEDICINE | 1995年 / 14卷 / 15期

关键词：

D O I：

10.1002/sim.4780141506

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

收藏

页码：1655 / 1657

页数：3

相关论文

共 7 条

[1]

CPMP Working Party on Efficacy of Medicinal Products, 1990, PHARMACOL TOXICOL, V67, P361

[2]

DARCY PF, 1992, 2ND P INT C HARM

[3]

DARCY PF, 1992, 1ST P INT C HARM

[4] THE CASE FOR CROSS-OVER TRIALS IN PHASE-III [J].

JONES, B ;

LEWIS, JA .

STATISTICS IN MEDICINE, 1995, 14 (9-10) :1025-1038

[5] STATISTICAL ISSUES IN THE REGULATION OF MEDICINES [J].

LEWIS, JA .

STATISTICS IN MEDICINE, 1995, 14 (02) :127-136

[6]

1994, BIOSTATISTICAL METHO

[7]

1988, GUIDELINE FORMAT CON